As if the words "disease management" weren't already a business killer, the results of a study on disease management for congestive heart failure presented at the American Heart Association meeting in November tapped another nail into the concept. Disease management usually refers to a kind of service-based oversight designed to improve both the clinical outcomes and the economics of treating patients. Congestive heart failure (CHF) has long been the target of such initiatives. It is the number one cause for hospitalizations in the US, and the health care system spends $40 billion on the disease annually. Disease management in heart failure thus seeks to manage medical therapies and symptoms efficiently to avoid frequent or long hospitalizations.
The South Texas CHF Disease Management Project, results of which were presented at AHA and published in Circulation, studied 1,069 patients that had heart failure and ventricular dysfunction, who were...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?